Who makes [14C]-LY3556050?

[14C]-LY3556050 is developed by Eli Lilly and Company.

Last reviewed 2026-04-19 · How we verify

[14C]-LY3556050

Eli Lilly and Company · Phase 1 active Small molecule

At a glance

Generic name	[14C]-LY3556050
Sponsor	Eli Lilly and Company
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C]-LY3556050 CI brief — competitive landscape report
[14C]-LY3556050 updates RSS · CI watch RSS
Eli Lilly and Company portfolio CI